QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.050955v1 306/2/463    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hata, A. N. Articles by Breyer, R. M. Search for Related Content PubMed PubMed Citation Articles by Hata, A. N. Articles by Breyer, R. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB TRITIUM

CELLULAR AND MOLECULAR

Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor

Departments of Pharmacology (A.N.H, R.M.B.), Cancer Biology (R.Z.), Medicine (R.Z., M.D.B., R.M.B), and Molecular Physiology and Biophysics (M.D.B.), and Vanderbilt Ingram Cancer Center (R.Z., M.D.B, R.M.B.), Vanderbilt University School of Medicine, Nashville, Tennessee

Prostaglandin D₂ (PGD₂), the predominant prostanoid produced by activated mast cells, is implicated in a variety of allergic diseases. PGD₂ exerts its effects through two G-protein coupled receptors, DP and CRTH2. PGD₂ mediates chemotaxis of eosinophils, basophils, and Th2 cells via CRTH2-evoked signaling, suggesting a role for this receptor in allergic disease. To characterize the mouse CRTH2 ortholog (mCRTH2), we amplified the mCRTH2 receptor gene and expressed it in HEK293 cells. Saturation ligand binding isotherms demonstrated high-affinity binding of [³H]PGD₂, with a K_d of 8.8 ± 0.8 nM. Competition binding assays with a panel unlabeled prostanoids demonstrated an order of affinity of 13,14-dihydro-15-keto-PGD₂ (DK-PGD₂) 15-deoxy-^12,14-PGJ₂ (15d-PGJ₂) PGD₂ PGJ₂. [³H]PGD₂ binding was also displaced by the nonsteroidal anti-inflammatory drug indomethacin, with a K_i value of 1.04 ± 0.13 µM. No [³H]PGD₂ displacement was detected using fluribrofen, ibuprofen, or aspirin as competitors at concentrations of up to 30 µM. PGD₂, DK-PGD₂, 15d-PGJ₂, and indomethacin each inhibited intracellular cAMP generation in stable transfectant ER293/mCRTH2 cells through a pertussis toxin (PTX) sensitive pathway, consistent with mCRTH2 coupling to a G_i heterotrimeric G-protein. Activation of mCRTH2 elicited chemotaxis of ER293/mCRTH2 cells in response to PGD₂, indomethacin, and 15d-PGJ₂. mCRTH2-dependent chemotaxis was inhibited by PTX and wortmannin, indicating dependence on G_i and PI 3-kinase signal transduction pathways. These data provide the first pharmacological and functional characterization of the mouse CRTH2 receptor.

Address correspondence to: Richard M. Breyer, Vanderbilt University, Division of Nephrology S3223MCN, 1161 21st Ave. South, Nashville, Tennessee 37232-2372. E-mail: rich.breyer{at}vanderbilt.edu

This article has been cited by other articles:

				S. A. Boehme, K. Franz-Bacon, E. P. Chen, T. W. Ly, Y. Kawakami, and K. B. Bacon Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2) Int. Immunol., June 1, 2009; 21(6): 621 - 632. [Abstract] [Full Text] [PDF]

				N. W. Lukacs, A. A. Berlin, K. Franz-Bacon, R. Sasik, L. J. Sprague, T. W. Ly, G. Hardiman, S. A. Boehme, and K. B. Bacon CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L767 - L779. [Abstract] [Full Text] [PDF]

				O. Schroder, Y. Yudina, A. Sabirsh, N. Zahn, J. Z. Haeggstrom, and J. Stein 15-deoxy-{Delta}12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells J. Lipid Res., May 1, 2006; 47(5): 1071 - 1080. [Abstract] [Full Text] [PDF]

				K. Cheng, T.-J. Wu, K. K. Wu, C. Sturino, K. Metters, K. Gottesdiener, S. D. Wright, Z. Wang, G. O'Neill, E. Lai, et al. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans PNAS, April 25, 2006; 103(17): 6682 - 6687. [Abstract] [Full Text] [PDF]

				K. Stamatakis, F. J. Sanchez-Gomez, and D. Perez-Sala Identification of Novel Protein Targets for Modification by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Mesangial Cells Reveals Multiple Interactions with the Cytoskeleton J. Am. Soc. Nephrol., January 1, 2006; 17(1): 89 - 98. [Abstract] [Full Text] [PDF]

				A. N. Hata, T. P. Lybrand, and R. M. Breyer Identification of Determinants of Ligand Binding Affinity and Selectivity in the Prostaglandin D2 Receptor CRTH2 J. Biol. Chem., September 16, 2005; 280(37): 32442 - 32451. [Abstract] [Full Text] [PDF]

				I. Spik, C. Brenuchon, V. Angeli, D. Staumont, S. Fleury, M. Capron, F. Trottein, and D. Dombrowicz Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse J. Immunol., March 15, 2005; 174(6): 3703 - 3708. [Abstract] [Full Text] [PDF]

				A. N. Hata, T. P. Lybrand, L. J. Marnett, and R. M. Breyer Structural Determinants of Arylacetic Acid Nonsteroidal Anti-Inflammatory Drugs Necessary for Binding and Activation of the Prostaglandin D2 Receptor CRTH2 Mol. Pharmacol., March 1, 2005; 67(3): 640 - 647. [Abstract] [Full Text] [PDF]

				A. Catalli and L. J. Janssen Augmentation of bovine airway smooth muscle responsiveness to carbachol, KCl, and histamine by the isoprostane 8-iso-PGE2 Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1035 - L1041. [Abstract] [Full Text] [PDF]

				A. Pozzi, X. Yan, I. Macias-Perez, S. Wei, A. N. Hata, R. M. Breyer, J. D. Morrow, and J. H. Capdevila Colon Carcinoma Cell Growth Is Associated with Prostaglandin E2/EP4 Receptor-evoked ERK Activation J. Biol. Chem., July 9, 2004; 279(28): 29797 - 29804. [Abstract] [Full Text] [PDF]

				K. Takeshita, T. Yamasaki, K. Nagao, H. Sugimoto, M. Shichijo, F. Gantner, and K. B. Bacon CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation Int. Immunol., July 1, 2004; 16(7): 947 - 959. [Abstract] [Full Text] [PDF]

				M. Shichijo, H. Sugimoto, K. Nagao, H. Inbe, J. A. Encinas, K. Takeshita, K. B. Bacon, and F. Gantner Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells Activation in Vivo Increases Blood Leukocyte Counts and Its Blockade Abrogates 13,14-Dihydro-15-keto-prostaglandin D2-Induced Eosinophilia in Rats J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 518 - 525. [Abstract] [Full Text] [PDF]